Clinical Trial Update: Evaluation of [18F]Fluoroethyl Triazole Labelled [Tyr3]-Octreotate Analogues for the Imaging of Neuroendocrine Tumours. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating a radiolabeled [Tyr3]-octreotate analogue for PET imaging of neuroendocrine tumors; the trial has completed and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Drugs mentioned

• [18F]Fluoroethyl triazole labelled [Tyr3]-Octreotate analogue

Snippet

Sponsor: Imperial College London | Conditions: Neuroendocrine Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-01